PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1933635

Dipyridamole-thallium imaging: minimum dose requirements.

C LaBonté·J Lette·M Cerino·A Gagnon·D Waters
View original source ↗Export metadata ↓

Abstract

A total of 372 consecutive dipyridamole-thallium studies were reviewed to determine if a relationship existed between the dose of dipyridamole administered and the likelihood that thallium images would show reversible defects. Men who received a dose of less than 31 mg were less likely to have thallium redistribution (P = 0.0001). Until the ideal study involving repeat testing with incremental dipyridamole doses on different days is carried out, the authors recommend that a minimal dose of 31 mg be administered for dipyridamole-thallium imaging.

Explore related subjects

Coronary VesselsDipyridamoleFemaleHeartHumansMaleMiddle AgedRadionuclide ImagingThallium RadioisotopesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C LaBonté, J Lette, M Cerino, A Gagnon, D Waters. 1991. Dipyridamole-thallium imaging: minimum dose requirements.. https://pubmed.ncbi.nlm.nih.gov/1933635/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Stress echocardiography in 11 patients with symptoms of ischemia and a myocardial bridge: no indication of a causal connection in 10 cases].

OBJECTIVE: To determine whether in patients with a myocardial bridge, systolic compression of the affected coronary branch may cause cardiac ischaemia and is of clinical relevance. DESIGN: Pilot inventory. METHOD: In 11 consecutive patients with an established myocardial bridge who presented with possible ischaemic symptoms angiographic dobutamine stress-echocardiography was used to visualize hypokinesia caused by ischaemia in the area ofmyocardium supplied by the bridged artery. RESULTS: Hypokinesia was observed in the area supplied by the bridged artery in one of the patients (9%). The symptoms in the other patients were not associated with the bridge. CONCLUSION: The clinical relevance of myocardial bridging appeared to be smaller than is generally assumed. In patients with known myocardial bridging and symptoms that could be caused by myocardial ischaemia, it should first be established that the bridge is actually causing the ischaemia before any therapeutic intervention aimed at the bridge is undertaken.

Coronary Vessels↗
PubMed2006

Double orifice tricuspid valve in an infant with tetralogy of Fallot.

Atrioventricular valve duplication, also known as double orifice valve, is an excitingly rare anomaly that can involve either the mitral or more uncommonly the tricuspid valve. Herein we describe a case of a double orifice tricuspid valve that prejudiced the complete repair in a symptomatic infant with tetralogy of Fallot.

Coronary Vessels↗